Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
-
Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on August 11th
-
Better Therapeutics, Inc. to Present at the Canaccord Genuity’s 41st Annual Growth Conference
-
AgroFresh Solutions to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Curaleaf Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference
-
EQ Inc. to Present at Canaccord Genuity Annual Growth Conference
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
-
CloudMD to Present at the Canaccord Genuity Growth Conference
-
Form 8.3 - [Marlowe plc - 03 08 2021] - (CGWL)
-
Form 8.3 - [Restore plc - 03 08 2021] - (CGWL)
-
Curaleaf Holdings, Inc. (CURLF) Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference
-
Quarterhill to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2022 Results
-
Impinj to Participate in Upcoming Investor Conferences
-
Minim to Present at Upcoming Virtual Investor Conferences
-
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
BlackSky to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Minim to Present at Upcoming Virtual Investor Conferences
-
Dynatronics Corporation Will Participate in Canaccord Genuity 41st Annual Growth Conference, August 10-12, 2021
-
Ameresco (AMRC) PT Lowered to $73 at Canaccord Genuity, Following Earnings
-
BioMedNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Featured on The Dealmaker Show, to Present at Canaccord Genuity Annual Growth Conference
-
Sequans Communications (SQNS) PT Lowered to $10 at Canaccord Genuity, Following Earnings
-
SolarEdge Technologies (SEDG) PT Raised to $280 at Canaccord Genuity
-
Form 8.3 - [Restore plc - Opening Disclosure - 22 07 2021] - (HHL)
-
Form 8.3 - [Marlowe plc - 22 07 2021 - CORRECTION] - (CGWL)
-
InMode to Participate in Upcoming August Conferences
-
Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option
-
Ameresco to Participate at Upcoming August Conference
-
Biohaven Pharmaceutical (BHVN) PT Raised to 'Street High' $150 at Canaccord Genuity
-
Pear Therapeutics to Participate in Upcoming Investor Conferences
-
Stoke Therapeutics to Present at Upcoming Investor Conferences in August
-
X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results
-
AcuityAds to Present at Canaccord Genuity's 41st Annual Growth Conference
-
Qualtrics to Participate in Upcoming Investor Conferences
-
ReCode Therapeutics to Participate in Upcoming August Investor Conferences
-
Bounteous Announces Strategic Investment from New Mountain Capital

